Body mass index and the prevalence of hypertension and dyslipidemia.
about
Obesity and cardiovascular disease risk factors in firefighters: a prospective cohort studyPsychosocial interventions for the maintenance of weight loss in obese adultsPsychosocial interventions for the maintenance of weight loss in obese adultsWeight reduction for primary prevention of stroke in adults with overweight or obesityRimonabant for overweight or obesitySurgery for morbid obesityOverweight and obesity in relation to cardiovascular disease risk factors among medical students in Crete, GreeceClinical risk factors for pre-eclampsia determined in early pregnancy: systematic review and meta-analysis of large cohort studiesVariant Near FGF5 Has Stronger Effects on Blood Pressure in Chinese With a Higher Body Mass Index.Treatment of metabolic syndromeObesity and non-alcoholic fatty liver disease: Disparate associations among Asian populationsSelf-reported long sleep in older adults is closely related to objective time in bedObesity and C-reactive protein levels among white, black, and hispanic US adultsComprehensive Map of Molecules Implicated in ObesityComparison of body mass index with waist circumference and skinfold-based percent body fat in firefighters: adiposity classification and associations with cardiovascular disease risk factorsThe Role of Metabolic Surgery on Blood Pressure Control.Sex differences in the risk profile of hypertension: a cross-sectional studyRelationships of obesity and fat distribution with atherothrombotic risk factors: baseline results from the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.Relationship of the dietary phytochemical index to weight gain, oxidative stress and inflammation in overweight young adultsThe adverse association of diabetes with risk of first acute myocardial infarction is modified by physical activity and body mass index: prospective data from the HUNT Study, Norway.Association between body mass index and onset of hypertension in men and women with and without diabetes: a cross-sectional study using national health data from the State of Kuwait in the Arabian Peninsula.An estimating equation approach to dimension reduction for longitudinal data.Blood Pressure Nomograms for Children and Adolescents by Age and Body Mass Index in Tehran, Iran.Comparison of clinical presentation, left ventricular morphology, hemodynamics, and exercise tolerance in obese versus nonobese patients with hypertrophic cardiomyopathyThe Obesity Epidemic: The United States as a Cautionary Tale for the Rest of the WorldTherapeutic strategies for targeting excessive central sympathetic activation in human hypertensionControlling Lipids AIDS in the Prevention of Type 2 Diabetes, Hypertension, and Cardiovascular Diseases.Dietary and cardio-metabolic risk factors in patients with Obstructive Sleep Apnea: cross-sectional study.The genetics of obesity and the metabolic syndrome.Does family history of metabolic syndrome affect the metabolic profile phenotype in young healthy individuals?Circulating alanine transaminase (ALT) and γ-glutamyl transferase (GGT), but not fetuin-A, are associated with metabolic risk factors, at baseline and at two-year follow-up: the prospective Cyprus Metabolism Study.Dietary factors related to body weight in adult Vietnamese in the rural area of Haiphong, Vietnam: the Korean Genome and Epidemiology Study (KoGES)Lactotripeptides and antihypertensive effects: a critical review.Obesity induces neuroinflammation mediated by altered expression of the renin-angiotensin system in mouse forebrain nuclei.Drug mechanisms to help in managing resistant hypertension in obesityCNR1 genotype influences HDL-cholesterol response to change in dietary fat intakePrevalence of dyslipidemia and its association with insomnia in a community based population in ChinaHigh prevalence of overweight, obesity, and hypertension with increased risk to cardiovascular disorders among adults in northwest Ethiopia: a cross sectional study.Retrospective case review of missed opportunities for primary prevention of stroke and TIA in primary care: protocol paper.Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors.
P2860
Q23912541-E35B722B-2589-4EBB-9A82-DDE8EF4ACF9CQ24186273-CAEDC14D-4466-479A-A989-1BC7760E2C01Q24243565-3FBD86F3-7471-4D18-860E-93AD648FF178Q24244016-754D3828-C46A-49A4-8809-C4DBC2335B80Q24244078-02099AAA-D88A-4255-AB5A-9A885E9EFF51Q24245694-173E29F5-0F57-4456-A6B8-22F656DC3224Q24794923-ECDBB925-C9C6-416D-9724-7A4A2C86C94DQ26752308-76A41085-746E-40CA-919C-586EA4190C80Q27304646-BD2587DB-ECB8-404E-B12F-AD4B6EF25F4AQ28168652-A1AB74E7-F8FA-4A8A-89EF-5FBB85316750Q28386598-F5E7A928-1D4D-43B9-8D00-92DAF429949CQ28393943-2C62B94C-A889-43E3-BE91-6F3B661B55E0Q28394601-C2B5F4BC-7051-49A6-81F0-FA43034EE97FQ28550240-A68FC47F-9069-456A-9337-2901961BA875Q28950718-314A1974-45C6-4095-ABF0-2B88C32B7093Q30249489-800E760D-F347-4577-8D30-3C8FE487AE0AQ30382457-AA6FBF6B-20C1-45E4-B0D2-DBE966557560Q30405237-2DAE3AE6-ADAB-44DF-A808-A1CF0998813CQ30419449-15FD1441-DEE2-4DEF-AED1-3ABB92E7EE60Q30858405-2AAE2733-FD09-4254-876A-544FE6E67CDDQ30965952-889579F6-AA92-4E9E-BEB5-3C773636D826Q31063820-E79E8D36-460D-4E80-AEC1-4CAD772312CAQ33575513-3413F047-7244-456B-A0B5-7FBC4BC6C8FFQ33701100-6C977FCB-53EF-4C97-8394-C86CA1B6F736Q33792107-4767CAB1-AAD3-4E40-B409-78A06143B91DQ33805761-82CD4887-1C9E-4EF1-A38F-E5159B26DCEDQ33810532-E1B90004-F744-4565-8FCC-1D59CF3F2EFBQ33828426-81B55664-3B6F-4F95-BC1C-E0C6D197ED03Q33886816-CEC02BFB-CD69-40F5-870C-BA6F09FDD305Q33895712-9D482A6F-ABE7-41B5-9D79-E31BBC163DA8Q33924942-C4DCF2D1-A283-451B-9203-7F026D9D3E1DQ33955654-C82C0A5A-5C08-4E61-8D16-C349C2EE3625Q34015048-4A0A027E-5E19-4E9E-863D-76839028657BQ34017275-45201D7E-B820-4148-A698-6539C27BB475Q34023578-900F8AC5-2C30-48D3-A815-245E01388A67Q34261731-BFCFF974-DDDA-4CA0-B0D6-36493C743F20Q34339877-9EC0B153-8378-4EB1-8873-ECDFF329A43EQ34491225-CBBDBDCB-1295-4651-80D9-663615942A2DQ34573465-66BAC1FB-2721-4F2D-B6B7-79C7B42276A2Q34608252-9DEA5763-ECF0-4194-B054-53903F28A1B8
P2860
Body mass index and the prevalence of hypertension and dyslipidemia.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh
2000年學術文章
@zh-hant
name
Body mass index and the prevalence of hypertension and dyslipidemia.
@en
Body mass index and the prevalence of hypertension and dyslipidemia.
@nl
type
label
Body mass index and the prevalence of hypertension and dyslipidemia.
@en
Body mass index and the prevalence of hypertension and dyslipidemia.
@nl
prefLabel
Body mass index and the prevalence of hypertension and dyslipidemia.
@en
Body mass index and the prevalence of hypertension and dyslipidemia.
@nl
P2093
P2860
P356
P1433
P1476
Body mass index and the prevalence of hypertension and dyslipidemia.
@en
P2093
Garrison R
Obarzanek E
P2860
P304
P356
10.1038/OBY.2000.79
P577
2000-12-01T00:00:00Z